GeneDx Holdings EBITDA Margin 2020-2024 | WGS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

GeneDx Holdings ebitda margin from 2020 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

GeneDx Holdings EBITDA Margin 2020-2024 | WGS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

GeneDx Holdings ebitda margin from 2020 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$121.5B
Cencora (COR)	$44.3B
ICON (ICLR)	$23.6B
DiDi Global (DIDIY)	$23.3B
Avantor (AVTR)	$17.6B
Natera (NTRA)	$15.5B
Revvity (RVTY)	$15.5B
Viatris (VTRS)	$13.8B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$11.7B
Medpace Holdings (MEDP)	$10.3B
Charles River Laboratories (CRL)	$10.2B
Sonic Healthcare (SKHHY)	$9.1B
Doximity (DOCS)	$8B
HealthEquity (HQY)	$7B
Bausch + Lomb (BLCO)	$6.7B
PACS (PACS)	$6B
Organon (OGN)	$4.9B
Life Times (LTH)	$4.8B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.1B
Concentras Parent (CON)	$2.8B
Ardent Health Partners (ARDT)	$2.6B
GoodRx Holdings (GDRX)	$2.6B
BrightSpring Health Services (BTSG)	$2.6B
Alignment Healthcare (ALHC)	$2.2B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$2B
AMN Healthcare Services Inc (AMN)	$1.6B
CareDx (CDNA)	$1.6B